Lummy Pharmaceutical
Overview
Chongqing Lummy Pharmaceutical Co., Ltd. engages in the research and development, manufacture, and sale of pharmaceutical products in China. It provides anti-tumor, anti-inflammatory, antibacterial, digestive, anti-virus, blood system, cardiovascular system, acid-base balance nutritional medicine, endocrine system drugs, tumor adjuvant medication, antifungal, and opioid receptor antagonists. The company was founded in 1999 and is headquartered in Chongqing, China.
Employees973
Market Cap$5.4B
Revenue$759.5M
Listed OnShenzhen Stock Exchange
Ticker300006
CEOMr. Rongzhao Qiu
HeadquartersChongqing